ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,122, issued on May 12, was assigned to H. Lee Moffitt Cancer Center and Research Institute Inc. (Tampa, Fla.).
"Affinity maturated TAG72 specific single chain antibodies" was invented by Hatem Soliman (Tampa, Fla.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compositions and methods for targeted treatment of TAG-72-expressing cancers. In particular, affinity maturated single chain variable fragment (scFv) antibodies that bind TAG-72 on cancer cells are disclosed."
The patent was filed on March 28, 2022, under Application No. 17/656,698.
*For further information, including images, charts and tables, please visit: http://patft.uspto.g...